论文信息 - Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001. - 字舞流文

Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.

M. Lunning | E. Purev | M. Palomba | S. Solomon | J. Arnason | A. Sehgal | N. Ghosh | C. Dehner | Tanya Siddiqi | K. Ogasawara | Leo I. Gordon | J. S. Abramson | C. Andreadis | David G. Maloney | Michael L Wang | Yeonhee Kim | Ana Kostic